том 202 издание 7 страницы 1051-1055

Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome

Тип публикацииJournal Article
Дата публикации2020-10-01
scimago Q1
Tоп 10% SciMago
wos Q1
white level БС1
SJR5.076
CiteScore23.8
Impact factor19.4
ISSN1073449X, 15354970
Critical Care and Intensive Care Medicine
Pulmonary and Respiratory Medicine
Для доступа к списку цитирований публикации необходимо авторизоваться.

Топ-30

Журналы

1
2
American Journal of Respiratory and Critical Care Medicine
2 публикации, 20%
Frontiers in Molecular Biosciences
1 публикация, 10%
npj Regenerative Medicine
1 публикация, 10%
Cytotherapy
1 публикация, 10%
EClinicalMedicine
1 публикация, 10%
Problemy Endokrinologii
1 публикация, 10%
Intensive Care Medicine Experimental
1 публикация, 10%
Signal Transduction and Targeted Therapy
1 публикация, 10%
1
2

Издатели

1
2
3
Springer Nature
3 публикации, 30%
American Thoracic Society
2 публикации, 20%
Elsevier
2 публикации, 20%
Frontiers Media S.A.
1 публикация, 10%
Endocrinology Research Centre
1 публикация, 10%
Wiley
1 публикация, 10%
1
2
3
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
 Войти с ORCID
Метрики
10
Поделиться
Цитировать
ГОСТ |
Цитировать
Simonson O. E. et al. Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome // American Journal of Respiratory and Critical Care Medicine. 2020. Vol. 202. No. 7. pp. 1051-1055.
ГОСТ со всеми авторами (до 50) Скопировать
Simonson O. E., Ståhle E., Hansen T., Wedin J. O., Larsson A., Mattsson M., Volchkov P., Le Blanc K., Rodin S., Grinnemo K. Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome // American Journal of Respiratory and Critical Care Medicine. 2020. Vol. 202. No. 7. pp. 1051-1055.
RIS |
Цитировать
TY - JOUR
DO - 10.1164/rccm.202003-0544LE
UR - https://www.atsjournals.org/doi/10.1164/rccm.202003-0544LE
TI - Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome
T2 - American Journal of Respiratory and Critical Care Medicine
AU - Simonson, Oscar E
AU - Ståhle, Elisabeth
AU - Hansen, Tomas
AU - Wedin, Johan O
AU - Larsson, Anders
AU - Mattsson, Mattias
AU - Volchkov, Pavel
AU - Le Blanc, Katarina
AU - Rodin, Sergey
AU - Grinnemo, Karl-Henrik
PY - 2020
DA - 2020/10/01
PB - American Thoracic Society
SP - 1051-1055
IS - 7
VL - 202
PMID - 32501728
SN - 1073-449X
SN - 1535-4970
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2020_Simonson,
author = {Oscar E Simonson and Elisabeth Ståhle and Tomas Hansen and Johan O Wedin and Anders Larsson and Mattias Mattsson and Pavel Volchkov and Katarina Le Blanc and Sergey Rodin and Karl-Henrik Grinnemo},
title = {Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2020},
volume = {202},
publisher = {American Thoracic Society},
month = {oct},
url = {https://www.atsjournals.org/doi/10.1164/rccm.202003-0544LE},
number = {7},
pages = {1051--1055},
doi = {10.1164/rccm.202003-0544LE}
}
MLA
Цитировать
Simonson, Oscar E., et al. “Five-Year Follow-up after Mesenchymal Stromal Cell–based Treatment of Severe Acute Respiratory Distress Syndrome.” American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 7, Oct. 2020, pp. 1051-1055. https://www.atsjournals.org/doi/10.1164/rccm.202003-0544LE.
Ошибка в публикации?